Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors (Q47860361)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2004

Language	Label	Description	Also known as
English	Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors	scientific article published in March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Towia A Libermann

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

15

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Kenneth C. Anderson

14

object named as

Kenneth C Anderson

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

author name string

Constantine S Mitsiades

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Nicholas S Mitsiades

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Ciaran J McMullan

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Vassiliki Poulaki

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Reshma Shringarpure

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Masaharu Akiyama

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Teru Hideshima

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Dharminder Chauhan

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Marie Joseph

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Carlos García-Echeverría

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Mark A Pearson

12

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Francesco Hofmann

13

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

221-230

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 is an autocrine growth factor in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor receptors and binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The insulin-like growth factor system and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the insulin-like growth factor-I receptor in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900050-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1535-6108(04)00050-9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15050914

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47860361&oldid=2173002398"